First-of-its-kind clinical trial will use reprogrammed adult stem cells to treat Parkinson’s / La prima sperimentazione clinica che utilizzerà cellule staminali adulte riprogrammate per il trattamento del morbo di Parkinson
First-of-its-kind clinical trial will use reprogrammed adult stem cells to treat Parkinson’s / La prima sperimentazione clinica che utilizzerà cellule staminali adulte riprogrammate per il trattamento del morbo di Parkinson Segnalato dal Dott. Giuseppe Cotellessa / Reported by Dr. Giuseppe Cotellessa Researchers in Japan today announced the launch of a clinical trial to treat Parkinson’s disease with neurological material derived from induced pluripotent stem (iPS) cells, mature cells chemically manipulated to return to an early stage of development from which they can theoretically differentiate into any of the body’s specialized cells. The study team will inject dopaminergic progenitors, a cell type that develops into neurons that produce dopamine, directly into a region of the brain known to play a key role in the neural degeneration associated with Parkinson’s disease. The effort is being led by Jun Takahashi, a neurosurgeon at Kyoto University's Center for i